Does transcatheter aortic valve implantation improve survival compared to surgical aortic valve replacement in intermediate and high-risk patients with severe aortic stenosis?
TAVI provides a significant survival benefit over SAVR at 2 years in intermediate and high-risk patients with severe aortic stenosis, especially via the transfemoral approach and in females.
Compared with SAVR, TAVI is associated with a significant survival benefit throughout 2 years of follow-up. Importantly, this superiority is observed irrespective of the TAVI device across the spectrum of intermediate and high-risk patients, and is particularly pronounced among patients undergoing transfemoral TAVI and in females.
Siontis et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: